Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience
- PMID: 32604413
- PMCID: PMC7337635
- DOI: 10.1093/cid/ciaa902
Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience
Abstract
Community-acquired coinfection in coronavirus disease 2019 (COVID-19) is not well defined. Current literature describes coinfection in 0-40% of COVID-19 patients. In this retrospective report, coinfection was identified in 3.7% of patients and 41% of patients admitted to intensive care (P < .005). Despite infrequent coinfection, antibiotics were used in 69% of patients.
Keywords: COVID-19; SARS-CoV-2; antibiotics; coinfection; superinfection.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous